We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Finch Therapeutics

News List

Finch Therapeutics’ C. Difficile drug gets breakthrough status pharmaceutical-technology
February 13, 2019
Microbial therapies developer Finch Therapeutics has received breakthrough therapy designation from the US Food and Drug Administration (FDA) for its investigational CP101 drug to treat recurrent Clostridium difficile (C. difficile) infection.....
Finch Therapeutics Group Raises $36 Million in Series B Financing firstwordpharma
March 02, 2018
Finch Therapeutics Group, Inc. (Finch) announced today the successful close of an oversubscribed $36 million Series B financing, bringing the total capital raised since the Company's launch to $77 million.